AxoGen, Inc. (NASDAQ:AXGN) Q1 2024 Earnings Call Transcript
Operator: Greetings, and welcome to the AxoGen, Inc. 2024 First Quarter Financial Results Conference Call. [Operator Instructions] As a reminder, this conference call is being recorded.
Stay updated with breaking news from Soft Tissue Matrix. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Operator: Greetings, and welcome to the AxoGen, Inc. 2024 First Quarter Financial Results Conference Call. [Operator Instructions] As a reminder, this conference call is being recorded.
Axogen announced the first surgical implantation of its Avive+ Soft Tissue Matrix, a resorbable, multi-layer, placenta-based allograft.
ALACHUA, Fla. and TAMPA, Fla., April 29, 2024 -- Axogen, Inc. , a global leader in developing and marketing innovative surgical solutions for peripheral nerve injuries, announces the first surgical...
Company Also Announces Departure of Angelo Scopelianos, Ph.D.ALACHUA, Fla. and TAMPA, Fla., Jan. 04, 2024 -- Axogen, Inc. , a global leader in developing and marketing innovative surgical...
Company Also Announces Departure of Angelo Scopelianos, Ph.D....